Company Filing History:
Years Active: 2001
Title: Camilo Anthony Leo Selwyn Colaco: Innovator in Pharmaceutical Formulations
Introduction
Camilo Anthony Leo Selwyn Colaco is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His innovative work has led to the development of a unique tablet dosage form that combines clavulanic acid and amoxycillin with a trehalose excipient.
Latest Patents
Colaco holds a patent for a tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient. This patent presents tablet formulations that include clavulanic acid or its salt, amoxycillin, and amorphous anhydrous trehalose. The trehalose is utilized in amounts ranging from 5 to 50%. Additionally, the formulation may incorporate desiccants, such as silica gel, or lubricants to enhance its effectiveness.
Career Highlights
Colaco is associated with Quadrant Holdings Cambridge Limited, where he applies his expertise in pharmaceutical innovations. His work focuses on improving drug formulations to enhance patient outcomes and medication stability. His dedication to research and development has positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Colaco has collaborated with notable colleagues, including Enda Martin Gribbon and Glen Patrick Martyn. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of pharmaceutical research.
Conclusion
Camilo Anthony Leo Selwyn Colaco is a distinguished inventor whose work in pharmaceutical formulations has made a significant impact. His innovative approach to drug development continues to contribute to advancements in the industry.